Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast Cancer
Authors:
- Patrice M. WitschenPWPatrice M. Witschen
- Thomas S. ChaffeeTCThomas S. Chaffee
- Nicholas J. BradyNBNicholas J. Brady
- Danielle N. HugginsDHDanielle N. Huggins
- Todd P. KnutsonTKTodd P. Knutson
- Rebecca S. LaRueRLRebecca S. LaRue
- Sarah A. MunroSMSarah A. Munro
- Lyubov TiegsLTLyubov Tiegs
- James B. McCarthyJMJames B. McCarthy
- Andrew C. NelsonANAndrew C. Nelson
- Kathryn L. SchwertfegerKSKathryn L. Schwertfeger
Open Access
Abstract
Cancer has been conceptualized as a chronic wound with a predominance of tumor promoting inflammation. Given the accumulating evidence that the microenvironment supports tumor growth, we investigated hyaluronan (HA)-CD44 interactions within breast cancer cells, to determine whether this axis directly impacts the formation of an inflammatory microenvironment. Our results demonstrate that breast cancer cells synthesize and fragment HA and express CD44 on the cell surface. Using RNA sequencing approaches, we found that loss of CD44 in breast cancer cells altered the expression of cytokine-related genes. Specifically, we found that production of the chemokine CCL2 by breast cancer cells was significantly decreased after depletion of either CD44 or HA. In vivo, we found that CD44 deletion in breast cancer cells resulted in a delay in tumor formation and localized progression. This finding was accompanied by a decrease in infiltrating CD206+ macrophages, which are typically associated with tumor promoting functions. Importantly, our laboratory results were supported by human breast cancer patient data, where increased HAS2 expression was significantly associated with a tumor promoting inflammatory gene signature. Because high levels of HA deposition within many tumor types yields a poorer prognosis, our results emphasize that HA-CD44 interactions potentially have broad implications across multiple cancers.Keywords
Funding Information
- National Institutes of Health (T32 fellowship, OD010993, R01HD095858, R01CA235385)
- American Cancer Society (132574-CSDG-18-139-01-CSM)
- Masonic Cancer Center, University of Minnesota (P30-CA077598)
This publication has 85 references indexed in Scilit:
- Primary tumours modulate innate immune signalling to create pre-metastatic vascular hyperpermeability fociNature Communications, 2013
- Identification of Function for CD44 Intracytoplasmic Domain (CD44-ICD)Journal of Biological Chemistry, 2012
- Hyaluronan Synthase 2 (HAS2) Promotes Breast Cancer Cell Invasion by Suppression of Tissue Metalloproteinase Inhibitor 1 (TIMP-1)Journal of Biological Chemistry, 2011
- Prostate Cancer Increases Hyaluronan in Surrounding Nonmalignant Stroma, and This Response Is Associated with Tumor Growth and an Unfavorable OutcomeThe American Journal of Pathology, 2011
- Agarose and polyacrylamide gel electrophoresis methods for molecular mass analysis of 5- to 500-kDa hyaluronanAnalytical Biochemistry, 2011
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasisNature, 2011
- Chemokine (C-C Motif) Ligand 2 Engages CCR2+ Stromal Cells of Monocytic Origin to Promote Breast Cancer Metastasis to Lung and BoneJournal of Biological Chemistry, 2009
- In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitroNature Protocols, 2007
- Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasisNature Cell Biology, 2006
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2003